Movers and Shakers

Alkermes announced Blair Jackson will be its new CEO.

Bitterroot Bio CEO Pavan Cheruvu steps away from the Company.

BioIVT‘s Auro Nair, Ph.D., has been appointed CEO and Chairman, replacing outgoing CEO Richard Haigh, Ph.D.

CSL CEO Paul McKenzie has retired. Gordon Naylor steps in as interim CEO as CSL searches for a permanent successor.

Helus Pharma appoints Michael Cola as CEO.

NodThera appoints Geoff McDonough, M.D., as CEO.

Quanta Therapeutics’ CMO Leonardo Faoro, M.D., moves to Alterome Therapeutics.

Pyxis Oncology, President & CEO & CMO Lara Sullivan, M.D., is pivoting away from the cancer biotech. Board member Thomas Civik has stepped into Lara’s roles.

Sensorion’s CEO Nawal Ouzren steps down.

Sanofi’s CEO Paul Hudson has been replaced with with Merck leader Belén Garijo.

Sarepta Therapeutics’ CEO Doug Ingram to step down.